Publikationliste Dr. Christoph Mayer

2011

Mayer CA, Pfeilschifter W, Lorenz MW, Nedelmann M, Bechmann I, Steinmetz H, Ziemann U. The perfect crime? CCSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):436-40. doi: 10.1136/jnnp.2010.231613. Epub 2011 Feb 4. PubMed PMID: 21296899; PubMed Central PMCID: PMC3061048.

​

Christoph Mayer, MD and Ulf Ziemann, MD, Truth is in the Eye of the Beholder. A Critical Review of the CCSVI Hypothesis,  Int J Clin Rev 2011;12:04 doi: 10.5275/ijcr.2011.12.04

​

Mayer CA, Ziemann U. CCSVI: is blinding the key?. Eur J Vasc Endovasc Surg. 2012 Jan;43(1):124-5. doi: 10.1016/j.ejvs.2011.09.014. Epub 2011 Sep 25. PubMed PMID: 21944996.

 

2012

Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Bergh FT, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Münch C, Winkelmann A, Zettl U UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation. 2012 Jan 19;9:14. doi: 10.1186/1742-2094-9-14. PubMed PMID: 22260418; PubMed Central PMCID: PMC3283476.

 

2013

Mayer CA, Brunkhorst R, Niessner M, Pfeilschifter W, Steinmetz H, Foerch C. Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases. PLoS One. 2013;8(4):e62101. doi: 10.1371/journal.pone.0062101. Print 2013. PubMed PMID: 23626774; PubMed Central PMCID: PMC3633915.

 

Jurcoane A, Wagner M, Schmidt C, Mayer C, Gracien RM, Hirschmann M, Deichmann R, Volz S, Ziemann U, Hattingen E. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis. J Magn Reson Imaging. 2013 Dec;38(6):1454-61. doi: 10.1002/jmri.24107. Epub 2013 Apr 1. PubMed PMID: 23554005.

 

2015

Barthelmes J, de Bazo AM, Pewzner-Jung Y, Schmitz K, Mayer CA, Foerch C, Eberle M, Tafferner N, Ferreirós N, Henke M, Geisslinger G, Futerman AH, Grösch S, Schiffmann S. Lack of ceramide synthase 2 suppresses the development of experimental autoimmune encephalomyelitis by impairing the migratory capacity of neutrophils. Brain Behav Immun. 2015 May;46:280-92. doi: 10.1016/j.bbi.2015.02.010. Epub 2015 Feb 16. PubMed PMID: 25697397.

 

Eberle M, Ebel P, Mayer CA, Barthelmes J, Tafferner N, Ferreiros N, Ulshöfer T, Henke M, Foerch C, de Bazo AM, Grösch S, Geisslinger G, Willecke K, Schiffmann S. Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils. Immunol Cell Biol. 2015 Oct;93(9):825-36. doi: 10.1038/icb.2015.47. Epub 2015 Apr 2. PubMed PMID: 25833068

​

2016

Tafferner N, Barthelmes J, Eberle M, Ulshöfer T, Henke M, deBruin N, Mayer CA, Foerch C, Geisslinger G, Parnham MJ, Schiffmann S. Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE. Eur J Immunol. 2016 Mar;46(3):570-81. doi: 10.1002/eji.201545782. Epub 2016 Jan 22. PubMed PMID: 26648339.

 

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C. Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol. 2016 Feb;79(2):206-16. doi: 10.1002/ana.24554. Epub 2015 Nov 26. PubMed PMID: 26537743.

​

Ottenlinger F, Schwiebs A, Pfarr K, Wagner A, Grüner S, Mayer CA, Pfeilschifter JM, Radeke HH. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes. Eur J Immunol. 2016 Apr;46(4):941-51. doi: 10.1002/eji.201545805. Epub 2016 Jan 13. PubMed PMID: 26683421.

​

Gracien RM, Jurcoane A, Wagner M, Reitz SC, Mayer C, Volz S, Hof SM, Fleischer V, Droby A, Steinmetz H, Zipp F, Hattingen E, Deichmann R, Klein JC. The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis. PLoS One. 2016;11(8):e0161036. doi: 10.1371/journal.pone.0161036. eCollection 2016. PubMed PMID: 27513853; PubMed Central PMCID: PMC4981438

​

Foerch C, Mayer CA, Berkefeld J, You SJ. Endovascular Treatment of a Severe Stroke Occurring in a Commercial Airplane Over the Sahara. Aerosp Med Hum Perform. 2016 Sep;87(9):825-9. doi: 10.3357/AMHP.4515.2016. PubMed PMID: 27634705

 

Ottenlinger FM, Mayer CA, Ferreirós N, Schreiber Y, Schwiebs A, Schmidt KG, Ackermann H, Pfeilschifter JM, Radeke HH. Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab. Front Pharmacol. 2016;7:412. doi: 10.3389/fphar.2016.00412. eCollection 2016. PubMed PMID: 27857690; PubMed Central PMCID: PMC5093125.

 

Gracien RM, Jurcoane A, Wagner M, Reitz SC, Mayer C, Volz S, Hof SM, Fleischer V, Droby A, Steinmetz H, Groppa S, Hattingen E, Deichmann R, Klein JC. Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis. J Magn Reson Imaging. 2016 Dec;44(6):1600-1607. doi: 10.1002/jmri.25297. Epub 2016 May 6. PubMed PMID: 27153293.

 

2017

Gracien RM, Reitz SC, Wagner M, Mayer C, Volz S, Hof SM, Fleischer V, Droby A, Steinmetz H, Groppa S, Hattingen E, Klein JC, Deichmann R. Comparison of two quantitative proton density mapping methods in multiple sclerosis. MAGMA. 2017 Feb;30(1):75-83. doi: 10.1007/s10334-016-0585-9. Epub 2016 Aug 20. PubMed PMID: 27544270

 

Schmitz K, Brunkhorst R, de Bruin N, Mayer CA, Häussler A, Ferreiros N, Schiffmann S, Parnham MJ, Tunaru S, Chun J, Offermanns S, Foerch C, Scholich K, Vogt J, Wicker S, Lötsch J, Geisslinger G, Tegeder I. Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis. Acta Neuropathol Commun. 2017 Jun 2;5(1):42. doi: 10.1186/s40478-017-0446-4. PubMed PMID: 28578681; PubMed Central PMCID: PMC5457661.

 

Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Weissert R, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Rückriem L, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Hellwig K. Influence of female sex and fertile age on neuromyelitis optica spectrum disorders. Mult Scler. 2017 Jul;23(8):1092-1103. doi: 10.1177/1352458516671203. Epub 2016 Oct 6. PubMed PMID: 27758954

 

Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Young KL, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl U, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Kleiter I. Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response. J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):639-647. doi: 10.1136/jnnp-2017-315603. Epub 2017 Jun 1. PubMed PMID: 28572277; PubMed Central PMCID: PMC5537514.

 

Abdelhak A, Hottenrott T, Mayer C, Hintereder G, Zettl UK, Stich O, Tumani H. CSF profile in primary progressive multiple sclerosis: Re-exploring the basics. PLoS One. 2017;12(8):e0182647. doi: 10.1371/journal.pone.0182647. eCollection 2017. PubMed PMID: 28797088; PubMed Central PMCID: PMC5552348.

 

Gotta M, Mayer CA, Huebner J. Use of complementary and alternative medicine in patients with multiple sclerosis in Germany. Complement Ther Med. 2018 Feb;36:113-117. doi: 10.1016/j.ctim.2017.12.006. Epub 2017 Dec 13. PubMed PMID: 29458916.

 

2018

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Krumbholz M, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl UK, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C. Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions. Neurol Neuroimmunol Neuroinflamm. 2018 Nov;5(6):e504. doi: 10.1212/NXI.0000000000000504. eCollection 2018 Nov. PubMed PMID: 30345331; PubMed Central PMCID: PMC6192689.

 

2020

Matura S, Köhler J, Reif A, Fusser F, Karakaya T, Scheibe M, Ehret F, Hartmann D, Kang JS, Mayer C, Prvulovic D, Pantel J. Intrinsic functional connectivity, CSF biomarker profiles and their relation to cognitive function in mild cognitive impairment. Acta Neuropsychiatr. 2020 Aug;32(4):206-213. doi: 10.1017/neu.2019.49. Epub 2019 Dec 5. PubMed PMID: 31801648

 

2023

Scherer S, Oberle SG, Kanev K, Gerullis AK, Wu M, de Almeida GP, Puleston DJ, Baixauli F, Aly L, Greco A, Nizharadze T, Becker NB, Hoesslin MV, Donhauser LV, Berner J, Chu T, McNamara HA, Esencan Z, Roelli P, Wurmser C, Kleiter I, Vehreschild MJGT, Mayer CA, Knolle P, Klingenspor M, Fumagalli V, Iannacone M, Prlic M, Korn T, Pearce EL, Höfer T, Schulz AM, Zehn D. Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development. Nat Immunol. 2023 Mar;24(3):501-515. doi: 10.1038/s41590-023-01436-x. Epub 2023 Feb 16. PubMed PMID: 36797499.

 

In Revision: 
Relevance of dedicated multiple sclerosis serum biomarkers in predicting contrast enhancement with gadolinium – Results from the REDUCE-GAD trial
European Journal of Neurology (EJoN-23-0173) Manuscript ID: EJoN-23-0173
Schaefer, Jan Hendrik; Schaller-Paule, Martin A.; Wenger, Katharina; Mayer, Christoph; Mann, Ulrike; Bickert, Alexander; Steffen, Falk; Bittner, Stefan; Yalachkov, Yavor; Förch, Christian